Results from the PRAGUE 14 trial reveals that opting for shortened pre-surgical interruption of anti-thrombotic therapy has no influence on perioperative complications in cardiac patients compared to a traditional one-week interruption. "Thus, there is no evidence to support changing the traditional approach of interrupting antithrombotic therapy one week before surgery," said lead investigator Petr Widimsky, MD., DrSc., from the Cardiocenter of Charles University, ...
Read More
No comments:
Post a Comment